XSHE
300622
Market cap694mUSD
Sep 30, Last price
14.58CNY
Name
Doctorglasses Chain Co Ltd
Chart & performance
P/E
31.30
P/S
3.42
EPS
0.47
Div yield, %
0.41%
Shrs. gr., 5y
6.27%
Rev. gr., 5y
15.69%
Revenues
1.36b
+13.10%
Net income
149m
+43.40%
CFO
297m
+7.78%
Dividend
Sep 09, 20260.16 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Doctorglasses Chain Co.,Ltd. engages in the retail of eyewear in China. It offers optical glasses; smart glasses; ready-to-wear glasses series, including sunglasses, reading glasses, etc.; contact lenses; soft/hard contact lenses; care solutions, and eye health peripheral products. The company provides eye examinations and fitting, wearing, and debugging, to after-sales visit. It sells its products through its store brands comprising doctor glasses, President Optical, Boojing, zèle, Concrete, and ZORRO, as well as through e-commerce and franchise channels. Doctorglasses Chain Co.,Ltd. was founded in 1993 and is headquartered in Shenzhen, China.
Key people
Alexander Liu
Chairman of the Board
Yunjie Ding
Deputy General Manager, Secretary of the Board · since 2024
Qingbai He
Deputy General Manager, Director · since 2024
Haiwen Kang
Chief Financial Officer, Deputy General Manager · since 2024
Yong Yang
Deputy General Manager · since 2024
Yanwen Zhou
Deputy General Manager · since 2024
Xinzhao Dai
Director · since 2025
Louisa Fan
General Manager, Director
Zhiming Liu
Director
Weiqi Xia
Director · since 2024
Qingqiu Zheng
Deputy General Manager, Director · since 2024
Jia Lan
Independent Director · since 2024
Suhua Liao
Independent Director · since 2024
Wei Wang
Independent Director · since 2022
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||